Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01730443 · ClinicalTrials.gov registry record

Blood Biomarkers of Injury and Outcome in Traumatic Brain Injury

A clinical trial, sponsored by Emory University.

Terminated
Registry status
576
Enrollment target

NCT01730443: Clinical Trial study, sponsored by Emory University.

NCT01730443 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 576 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01730443 was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
576 participants
Enrollment target

Study Summary

Blood samples will be drawn on traumatic brain injury patients who are participating in the ProTECT III study.

Primary Outcome

Blood will be collected/processed at baseline, 24 hours and 48 hours.

Trial Details

FieldValue
Enrollment Target 576 participants
Start Date 2011-07
Est. Completion 2014-07
Emory University

1,208 total trials

Why NCT01730443 stopped before completion

NCT01730443 is an observational study that tracks outcomes without assigning an intervention. The registered 576 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01730443 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01730443 about?

NCT01730443 is a clinical study titled "Blood Biomarkers of Injury and Outcome in Traumatic Brain Injury". Blood samples will be drawn on traumatic brain injury patients who are participating in the ProTECT III study.

What is the current status of trial NCT01730443?

This trial is currently terminated. The enrollment target is 576 participants. The study started on 2011-07. Estimated completion is 2014-07.

Who is sponsoring clinical trial NCT01730443?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04931810 · 576 participants · NA

    Urban and Reservation Implementation of All Nations Breath of Life

  • NCT05179369 · 576 participants · NA

    Well-Mama Community Doula Navigator Study

  • NCT06398509 · 576 participants · NA

    A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children

  • NCT02610439 · 575 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01730443, the US trial registry maintained by the National Library of Medicine. NCT01730443 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.